Balanced news tone
News Sentiment
BAFNAPH sentiment intelligence
Bafna Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-5.5% over one week, +23.7% over four weeks, trend active, and materially above fair value.
Bafna Pharmaceuticals Files SEBI Demat Compliance Certificate for June Quarter
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Bafna Pharmaceuticals Files SEBI Demat Compliance Certificate for June Quarter
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jul 2026 10:52
- Source
- TipRanks
Bafna Pharmaceuticals promoters report no share encumbrance in FY26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- scanx.trade
Bafna Pharmaceuticals promoter confirms no share encumbrance in FY26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- scanx.trade
Bafna Pharmaceuticals board to consider FY26 results on May 29
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- scanx.trade
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
Bafna Pharmaceuticals Clarifies Share Price Movement Following Stock Exchange Queries
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- scanx.trade
Bafna Pharmaceuticals Ltd. Share Price Today - Bafna Pharmaceuticals Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Sep 2025 05:35
- Source
- CNBC TV18
In Talks With Multinational Pharma Cos For Acquisition Of Brands: Bafna Pharmaceuticals
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 11 Feb 2025 08:02
- Source
- BW Healthcare
Bafna Pharmaceuticals standalone net profit rises 75.88% in the December 2022 quarter
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 10 Feb 2023 08:00
- Source
- Business Standard
Bafna Pharma sells India branded generic drug business to Strides Acrolab
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2014 07:00
- Source
- Business Standard
Mylan, two Indian companies line up to buy Bafna Pharmaceuticals
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 Nov 2013 08:00
- Source
- The Economic Times